Risultati della ricerca - Stephan R. Vavricka
- Mostra 1 - 20 risultati su 71
- Vai alla pagina seguente
-
1
Anemia in Inflammatory Bowel Disease: An Under-Estimated Problem? di Gerhard Rogler, Stephan R. Vavricka
Pubblicazione 2015Revisão -
2
Mucosal healing and deep remission: What does it mean? di Gerhard Rogler, Stephan R. Vavricka, Alain Schoepfer, Péter L. Lakatos
Pubblicazione 2013Revisão -
3
The Genetics of Inflammatory Bowel Disease di Jasmina El Hadad, Philipp Schreiner, Stephan R. Vavricka, Thomas Greuter
Pubblicazione 2023Revisão -
4
-
5
Malignancies in Inflammatory Bowel Disease di Thomas Greuter, Stephan R. Vavricka, Alexander König, Laurent Beaugerie, Michael Scharl
Pubblicazione 2020Revisão -
6
Serum Protein Electrophoresis: An Underused but Very Useful Test di Stephan R. Vavricka, Emanuel Burri, Christoph Beglinger, Lukas Degen, Markus G. Manz
Pubblicazione 2009Revisão -
7
Gender Differences in Inflammatory Bowel Disease di Thomas Greuter, Christine N. Manser, Valérie Pittet, Stephan R. Vavricka, Luc Biedermann
Pubblicazione 2020Revisão -
8
Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment di Benjamin Misselwitz, Daniel Pohl, Heiko Frühauf, Michael Fried, Stephan R. Vavricka, Mark Fox
Pubblicazione 2013Artigo -
9
-
10
Nutrition in Inflammatory Bowel Disease di Philipp Schreiner, Maude Martinho-Grueber, Diana Studerus, Stephan R. Vavricka, Herbert Tilg, Luc Biedermann
Pubblicazione 2020Revisão -
11
-
12
-
13
Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI di Alain Schoepfer, Christoph Beglinger, Alex Straumann, Michael Trummler, Stephan R. Vavricka, Lukas E. Bruegger, Frank Seibold
Pubblicazione 2009Artigo -
14
-
15
Maintenance Treatment Of Eosinophilic Esophagitis With Swallowed Topical Steroids Alters Disease Course Over A 5-Year Follow-up Period In Adult Patients di Thomas Greuter, Ekaterina Safroneeva, Christian Bussmann, Luc Biedermann, Stephan R. Vavricka, David A. Katzka, Alain Schoepfer, Alex Straumann
Pubblicazione 2018Artigo -
16
-
17
Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes di Alain Schoepfer, Christoph Beglinger, Alex Straumann, Ekaterina Safroneeva, Yvonne Romero, David Armstrong, Carsten Schmidt, Michael Trummler, Valérie Pittet, Stephan R. Vavricka
Pubblicazione 2013Artigo -
18
Systematic Assessment of Factors Influencing Preferences of Crohnʼs Disease Patients in Selecting an Anti-Tumor Necrosis Factor Agent (CHOOSE TNF TRIAL) di Stephan R. Vavricka, Nicoletta Bentele, Michael Scharl, Gerhard Rogler, Jonas Zeitz, Pascal Frei, Alex Straumann, Janek Binek, Alain Schoepfer, Michael Fried
Pubblicazione 2011Artigo -
19
Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up di Montserrat Fraga, Nicolas Fournier, Ekaterina Safroneeva, Valérie Pittet, Sébastien Godat, Alex Straumann, Andreas Nydegger, Stephan R. Vavricka, Darius Moradpour, Alain Schoepfer
Pubblicazione 2016Artigo -
20
Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease di Christian Mottet, Alain Schoepfer, Pascal Juillerat, Jacques Cosnes, Florian Froehlich, Vera Kessler-Brondolo, Frank Seibold, Gerhard Rogler, Stephan R. Vavricka, Pierre Michetti
Pubblicazione 2016Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Internal medicine
Disease
Inflammatory bowel disease
Gastroenterology
Crohn's disease
Ulcerative colitis
Biology
Intensive care medicine
Immunology
Cohort
Pathology
Biochemistry
Inflammatory Bowel Diseases
Chemistry
Surgery
Cell biology
Gene
Inflammation
Infliximab
Tumor necrosis factor alpha
Adalimumab
Cohort study
Dermatology
Environmental health
Paleontology
Anemia
Calprotectin
Cancer
Clinical trial